Biocept Announces In-Network Agreement with Blue Cross Blue Shield of Illinois

Biocept, Inc. BIOC announces that it has entered into an agreement with Blue Cross Blue Shield of Illinois (BCBS IL) allowing its members access to Biocept's broad menu for liquid biopsy testing.  With the addition of BCBS IL's more than eight million members, the number of patients with access to Biocept's liquid biopsy assays through their healthcare insurance plan has increased to approximately 133 million. "BCBS IL is the largest health plan in Illinois and is our first agreement with a plan in the Blue Cross Blue Shield system," said Michael W. Nall, President and CEO of Biocept.  "We view this agreement as another indication of the growing awareness by healthcare providers of the important role liquid biopsy can have in the treatment of patients with cancer.  For Biocept, gaining health plan coverage for our tests is a key aspect of our reimbursement strategy." "For a significant number of patients with See full press release